Tirzepatide

Tirzepatide is a synthetic peptide medication that acts as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It is administered via subcutaneous injection.

This medication is primarily used for the treatment of type 2 diabetes mellitus, helping to improve glycemic control. It is also indicated for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity.